Table 4.
Toxicities in trials comparing rituximab maintenance vs observation in follicular lymphoma
Reference | No of. patients | Grade 3-4 AE | Neutropenia (grade 3-4) | Grade 3-4 Infections |
Haisworth et al[16] |
62 |
9% vs 4% |
2% vs 0% |
0 |
Ghielmini et al[14] Martinelli et al[19] |
185 |
28% vs 20% |
18% vs 17% |
NA |
Hochster et al[17] |
228 |
NA |
3% vs 1% |
1% vs 1% |
Forstpointner et al[10] |
105 |
NA |
13% vs 6% |
4% vs 3% |
van Oers et al[6] |
334 |
NA |
10.8% vs 5.4%(P = 0.07) |
9% vs 2.4% (P = 0.009) |
Salles et al[18,23] | 1018 | 23% vs 16% | 4% vs 1% | 4% vs 1% |